GI Dynamics Gets FDA Conditional OK for a Trial of its EndoBarrier Obesity Treatment

GI Dynamics announced it has received conditional approval from the FDA to start a pivotal clinical trial of its EndoBarrier device for the treatment of patients who have uncontrolled Type 2 diabetes and who are obese.
Boston Globe